Loading insider details...
Beta
Latest Form 4 (Jun 29, 2026): Grant/Award of 26,000 CLDX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 29, 2026 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 26,000 | n/a |
| Jun 23, 2026 | GLAUKOS Corp (GKOS) | Grant/Award | 2,987 | n/a |
| May 4, 2026 | Seaport Therapeutics, Inc. (SPTX) | Conversion | 13,406 | n/a |
| Jan 8, 2026 | GLAUKOS Corp (GKOS) | Grant/Award | 623 | n/a |
| Jun 9, 2025 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 33,000 | n/a |
| Jun 2, 2025 | GLAUKOS Corp (GKOS) | Grant/Award | 461 | n/a |
| Jun 12, 2024 | 2seventy bio, Inc. (TSVT) | Grant/Award | 12,050 | n/a |
| Jun 4, 2024 | GLAUKOS Corp (GKOS) | Grant/Award | 1,716 | n/a |
| Mar 18, 2024 | Karuna Therapeutics, Inc. (KRTX) | Disposition to Issuer | 990 | $326.7K |
| Jan 4, 2024 | GLAUKOS Corp (GKOS) | Grant/Award | 895 | n/a |